Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Emepronium

Known as: Benzenepropanaminium, N-ethyl-N,N,alpha-trimethyl-gamma-phenyl-, Emepronium [Chemical/Ingredient] 
A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
BACKGROUND Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or urge incontinence). The… Expand
Review
2002
Review
2002
BACKGROUND Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or urge incontinence). The… Expand
Review
1991
Review
1991
Drug-induced esophagitis is being recognized increasingly in the past few years. We have reviewed 175 cases with a view to… Expand
Review
1987
Review
1987
A review of the 127 cases of drug-induced esophagitis reported since 1970 indicates that commonly used medications may be a… Expand
Highly Cited
1983
Highly Cited
1983
In a randomised double-blind cross-over trial of 19 females with motor urge incontinence but without bladder suspension defect… Expand
1982
1982
The effect of the anticholinergic agent, emepronium bromide (Cetiprin), was studied in a double blind crossover study of a group… Expand
Highly Cited
1982
Highly Cited
1982
Drug histories were obtained from 76 patients at the time of initial Eder-Puestow dilatation for benign oesophageal stricture… Expand
1978
1978
For more than 20 years emepronium bromide has been used in the treatment of urgency and urge incontinence. Different dosages have… Expand
1973
1973
The effect of a quaternary nitrogen compound, Emepronium bromide (Cetiprin), on micturition parameters was investigated. In seven… Expand
1969
1969
A double-blind cross-over trial of emepronium bromide (Cetiprin) in nocturnal frequency of micturition in a group of elderly… Expand